Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANNX Annexon, Inc.

盘前交易 09-27 05:58:19 EDT

6.12

-0.01

-0.16%

最高6.29	最低5.88	成交量124.25万
今开6.19	昨收6.13	日振幅6.69%
总市值6.47亿	流通市值4.22亿	总股本1.06亿
成交额756.39万	换手率1.80%	流通股本6,895万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANNX","market":"US","secType":"STK","nameCN":"Annexon, Inc.","latestPrice":6.12,"timestamp":1727380800000,"preClose":6.13,"halted":0,"volume":1242506,"delay":0,"floatShares":68953262,"shares":105653962,"eps":-1.133442,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.01,"latestTime":"09-27 05:58:19 EDT","open":6.19,"high":6.29,"low":5.88,"amount":7563931.710852,"amplitude":0.066884,"askPrice":6.93,"askSize":100,"bidPrice":5.99,"bidSize":416,"shortable":3,"etf":0,"ttmEps":-1.133442,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727443800000},"adr":0,"listingDate":1595563200000,"adjPreClose":6.12,"postHourTrading":{"tag":"盘后","latestPrice":6.12,"preClose":6.12,"latestTime":"19:31 EDT","volume":21101,"amount":129138.38,"timestamp":1727393468504},"volumeRatio":0.465661093156972,"impliedVol":0.6153,"impliedVolPercentile":0.1514},"requestUrl":"/m/hq/s/ANNX/wiki","defaultTab":"wiki","newsList":[{"id":"2470441884","title":"Annexon, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470441884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470441884?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:59","pubTimestamp":1727207944,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时59分，Annexon, Inc.股票出现波动，股价快速下跌5.04%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925035904ab65b050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925035904ab65b050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2469391149","title":"Annexon, Inc.盘中异动 早盘急速下挫5.12%报6.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469391149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469391149?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:03","pubTimestamp":1727103792,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时03分，Annexon, Inc.股票出现波动，股价快速下跌5.12%。截至发稿，该股报6.67美元/股，成交量26.8577万股，换手率0.25%，振幅5.69%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323031298e38774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323031298e38774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2460065875","title":"Annexon, Inc.盘中异动 下午盘急速下跌5.05%报5.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460065875","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460065875?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:13","pubTimestamp":1724094813,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时13分，Annexon, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报5.79美元/股，成交量122.157万股，换手率1.16%，振幅8.20%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.50%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003133497199312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003133497199312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2459473765","title":"Annexon, Inc.盘中异动 快速拉升5.35%报5.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459473765","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459473765?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:04","pubTimestamp":1723730673,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时04分，Annexon, Inc.股票出现波动，股价大幅上涨5.35%。截至发稿，该股报5.91美元/股，成交量7.699万股，换手率0.07%，振幅2.32%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815220433ab5dd9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815220433ab5dd9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2459107708","title":"Annexon, Inc.盘中异动 快速下跌5.01%报5.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459107708","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459107708?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:43","pubTimestamp":1723653821,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时43分，Annexon, Inc.股票出现异动，股价大幅跳水5.01%。截至发稿，该股报5.40美元/股，成交量25.4212万股，换手率0.24%，振幅5.63%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815004341968263ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815004341968263ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2459110671","title":"美国研究综述-Agenus、Guardant Health、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110671?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:49","pubTimestamp":1723618162,"startTime":"0","endTime":"0","summary":"    路透8月14日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Agenus、Guardant Health 和 Zoetis。要闻              * Agenus Inc   ：B. Riley将目标价从42美元下调至18美元             * Clorox   ：杰富瑞将目标价从 148 美元上调至 151 美元             * Guardant Health Inc   ：Raymond James将目标价从28美元上调至36美元             * 星巴克  ：Stifel将其评级从 \"持有 \"上调至 \"买入\"；将目标价从80美元上调至110美元             * Zoetis Inc   ：Piper Sandler将目标价从195美元上调至210美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXC","AMCX","LU1363072403.SGD","LU0149725797.USD","HEI","FE","AGEN","BHF","LU2506952410.USD","BOLD","HD","ETR","GH","ANNX","ES","CPK","CMS","IBTA","BALL","LU2211815571.USD","AIZ","DUK","D","WTRG","FEMY","AEP","ADVM","FTHM","CNP","LU2506952337.HKD","CLX","ATKR","BKH","SKY","ED","EMR","IDXX","MO","AWK","EIX","SLRN","LU0942090050.USD","FENC","CTNM","ALUR","LU","LU0205193047.USD"],"gpt_icon":1},{"id":"2459967472","title":"Annexon, Inc.2024财年第二财季实现净利润-29.61百万美元，同比增加15.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459967472","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459967472?lang=zh_cn&edition=full","pubTime":"2024-08-13 08:00","pubTimestamp":1723507218,"startTime":"0","endTime":"0","summary":"8月13日，Annexon, Inc.公布财报，公告显示公司2024财年第二财季净利润为-29.61百万美元，同比增加15.86%；其中营业收入为0.00美元，每股基本收益为-0.23美元。从资产负债表来看，Annexon, Inc.总负债45.01百万美元，其中短期债务2.35百万美元，资产负债比为0.10，流动比率为0.22。机构评级：截至2024年8月13日，当前有6家机构对Annexon, Inc.目标价做出预测，其中目标均价为15.67美元，其中最低目标价为10.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130800279593995d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130800279593995d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX"],"gpt_icon":0},{"id":"2458982438","title":"Annexon Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458982438","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458982438?lang=zh_cn&edition=full","pubTime":"2024-08-12 23:03","pubTimestamp":1723475020,"startTime":"0","endTime":"0","summary":"   * Annexon Inc   公布的截至一月份的季度调整后每股亏损23美分，高于去年同期的每股-47美分。八位分析师对该季度的平均预期是每股亏损 23 美分。* Annexon Inc 公布的本季度每股收益为亏损 23 美分。* 该公司当季亏损 2961 万美元。* Annexon Inc 本季度股价上涨了 11.8%，今年迄今为止上涨了 20.7%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Annexon Inc 的 12 个月目标价中位数为 14.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Annexon Inc 报告截至一月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2457924822","title":"Annexon, Inc.盘中异动 股价大跌5.11%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457924822","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457924822?lang=zh_cn&edition=full","pubTime":"2024-08-08 01:02","pubTimestamp":1723050145,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日01时02分，Annexon, Inc.股票出现异动，股价快速跳水5.11%。截至发稿，该股报5.38美元/股，成交量26.933万股，换手率0.26%，振幅7.94%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为2.29%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808010225aefdbe55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808010225aefdbe55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2457023690","title":"Annexon, Inc.盘中异动 早盘快速拉升6.38%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023690","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023690?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951104,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时31分，Annexon, Inc.股票出现异动，股价急速上涨6.38%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为690.53%、274.27%、201.49%，振幅较大的相关个股有Vbi Vaccines, Inc.、Moleculin Biotech, Inc.、Cingulate Inc.，振幅分别为47.69%、11.20%、10.37%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080621314597198920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080621314597198920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2457729012","title":"预计在2026年下半年公布主要数据的Annexon公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729012","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457729012?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:13","pubTimestamp":1722860039,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2457290177","title":"Annexon公司已在C1Q抑制剂Anx007的Archer II临床试验第三阶段开始给患者进行剂量给药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457290177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457290177?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:13","pubTimestamp":1722860035,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ANNX","BK1141","BK4139","03347","BK1576","BK1583"],"gpt_icon":0},{"id":"2457884729","title":"Annexon就地理性萎缩患者的Archer II全球注册计划提供更新。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457884729","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457884729?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:00","pubTimestamp":1722859203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2456323179","title":"Annexon Inc    预计每股亏损 23 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456323179","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456323179?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:01","pubTimestamp":1722614478,"startTime":"0","endTime":"0","summary":"   * Annexon Inc    预计在8月5日公布截至2024年6月30日的业绩时，季度收入将不会有任何变化(预计)。*    * LSEG 的分析师平均预计 Annexon Inc 每股亏损 23 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 8 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Annexon Inc 的 12 个月目标价中位数为 14.00 美元，高于其最新收盘价 6.10 美元。8月2日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Annexon Inc    预计每股亏损 23 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANNX"],"gpt_icon":0},{"id":"2456794284","title":"Annexon, Inc.盘中异动 股价大跌5.08%报5.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456794284","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456794284?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605464,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分，Annexon, Inc.股票出现异动，股价大幅跳水5.08%。截至发稿，该股报5.79美元/股，成交量2.318万股，换手率0.02%，振幅0.66%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213104af95a569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213104af95a569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2456468652","title":"Annexon, Inc.盘中异动 股价大跌5.15%报6.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456468652","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456468652?lang=zh_cn&edition=full","pubTime":"2024-08-02 02:44","pubTimestamp":1722537873,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日02时44分，Annexon, Inc.股票出现波动，股价快速下跌5.15%。截至发稿，该股报6.08美元/股，成交量73.6642万股，换手率0.70%，振幅6.47%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080202443398e34b29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080202443398e34b29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2455159490","title":"Annexon, Inc.盘中异动 临近午盘股价大涨5.15%报6.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455159490","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455159490?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:36","pubTimestamp":1722440200,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日23时36分，Annexon, Inc.股票出现异动，股价急速拉升5.15%。截至发稿，该股报6.53美元/股，成交量23.4411万股，换手率0.22%，振幅4.83%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731233641aefc7d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731233641aefc7d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2455951599","title":"Annexon, Inc.盘中异动 早盘急速下挫5.19%报6.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455951599","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455951599?lang=zh_cn&edition=full","pubTime":"2024-07-30 23:06","pubTimestamp":1722351988,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日23时06分，Annexon, Inc.股票出现波动，股价急速下跌5.19%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Imunon, Inc.、Cue Biopharma, Inc.、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Imunon, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1809.51%、1114.26%、966.00%，振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Orgenesis Inc.，振幅分别为74.79%、55.88%、50.00%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730230629aefc35f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730230629aefc35f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2454749058","title":"Annexon, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454749058","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454749058?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:56","pubTimestamp":1721915786,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时56分，Annexon, Inc.股票出现异动，股价急速拉升5.42%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1522.28%、370.11%、155.26%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为114.90%、98.60%、50.00%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725215626941fa9fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725215626941fa9fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2453288295","title":"Annexon, Inc.盘中异动 临近午盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453288295","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453288295?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:52","pubTimestamp":1721836368,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时52分，Annexon, Inc.股票出现波动，股价大幅拉升5.45%。截至发稿，该股报6.19美元/股，成交量42.5611万股，换手率0.40%，振幅8.86%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242352499681fe14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242352499681fe14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annexonbio.com","stockEarnings":[{"period":"1week","weight":-0.1288},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.249},{"period":"6month","weight":-0.1464},{"period":"1year","weight":1.5823},{"period":"ytd","weight":0.348}],"compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0516},{"period":"6month","weight":0.0941},{"period":"1year","weight":0.3433},{"period":"ytd","weight":0.2041}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annexon, Inc.于2011年3月3日根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于开发针对经典补体介导的身体，大脑和眼睛疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.043018},{"month":2,"riseRate":0.5,"avgChangeRate":0.014392},{"month":3,"riseRate":0.25,"avgChangeRate":-0.117935},{"month":4,"riseRate":0.25,"avgChangeRate":-0.084387},{"month":5,"riseRate":0.75,"avgChangeRate":-0.02094},{"month":6,"riseRate":1,"avgChangeRate":0.11455},{"month":7,"riseRate":0.5,"avgChangeRate":0.138193},{"month":8,"riseRate":0.4,"avgChangeRate":-0.002079},{"month":9,"riseRate":0.8,"avgChangeRate":0.069297},{"month":10,"riseRate":0,"avgChangeRate":-0.174969},{"month":11,"riseRate":0.75,"avgChangeRate":0.099167},{"month":12,"riseRate":0.5,"avgChangeRate":0.128325}],"exchange":"NASDAQ","name":"Annexon, Inc.","nameEN":"Annexon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annexon, Inc.,ANNX,Annexon, Inc.股票,Annexon, Inc.股票老虎,Annexon, Inc.股票老虎国际,Annexon, Inc.行情,Annexon, Inc.股票行情,Annexon, Inc.股价,Annexon, Inc.股市,Annexon, Inc.股票价格,Annexon, Inc.股票交易,Annexon, Inc.股票购买,Annexon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}